MLTX vs GILD: Which Stock is Better?
Side-by-side comparison of Moonlake Immunotherapeutics and Gilead Sciences Inc in 2026
MLTX
Moonlake Immunotherapeutics
$16.33
GILD
Gilead Sciences Inc
$124.14
Key Metrics Comparison
| Metric | MLTX | GILD | Winner |
|---|---|---|---|
| Market Cap | $1.16B | $154.03B | GILD |
| P/E Ratio | N/A | 19.22 | GILD |
| EPS (TTM) | $N/A | $6.46 | GILD |
| Revenue Growth | 0.0% | 0.0% | GILD |
| Gross Margin | 0.0% | 78.7% | GILD |
Analyze MLTX
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is MLTX or GILD a better investment?
Comparing MLTX and GILD: Moonlake Immunotherapeutics has a market cap of $1.16B while Gilead Sciences Inc has $154.03B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between MLTX and GILD?
MLTX (Moonlake Immunotherapeutics) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: MLTX or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: MLTX or GILD?
GILD has higher revenue growth at 0.0% vs 0.0% for MLTX.
Which company is more profitable: MLTX or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.7% compared to 0.0% for MLTX.
Which is the larger company: MLTX or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $154.03B compared to $1.16B for MLTX.
Should I buy MLTX or GILD in 2026?
Both MLTX and GILD have investment merit. MLTX trades at $16.33 while GILD trades at $124.14. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between MLTX and GILD stock?
Key differences: Market Cap ($1.16B vs $154.03B), P/E Ratio (N/A vs 19.2x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 78.7%).